Meeting Overview
Chicago Marriott Downtown Magnificent Mile
11.25 AMA Category 1, AAFP, 11.25 AANP
Fresh Look at the Real-World Challenges
of Primary Care
Pri-Med Updates is designed to reflect the practitioner's patient appointment schedule. The curriculum is composed of 9 different symposia, each focused on a specific clinical condition and each presented by nationally-recognized speakers. Sessions include didactic presentations as well as interactive, case-based learning opportunities. The goal is to connect current research and leading opinion to insights you can put into practice at once, while enabling you to earn a maximum of 11.25 AMA PRA Category 1 Credit(s)TM or AANP contact hours of continuing education at no cost.
Customize your own schedule.
Come for 1 session, 1 day or all 9 sessions.
|
|
"I think this format is excellent for busy practitioners who need a chance to get away from the office and concentrate on medical advances and to renew their understanding of basic medical concepts."
J. Early, MD
Pri-Med Attendee
|
|
Goals and Objectives
Attend this continuing education activity and you will be able to:
- Earn up to 11.25 AMA PRA Category 1 Credit(s)TM or AANP contact hours of continuing education.
- Network with colleagues who live and practice in your area.
- Take advantage of complimentary world-class continuing medical education.
- Interact with expert faculty during dedicated Q&A throughout the program.
- Test your knowledge and receive immediate feedback on patient care scenarios using an Audience Response System.
This activity is intended for primary care providers currently engaged in patient care.
Find additional Pri-Med educational programs in your area.
Marketing Partners
Pri-Med partners with local healthcare associations, managed care organizations, and publications in order to ensure that all practicing clinicians have the opportunity to attend. Pri-Med would like to thank the following partners for this program to date:
Aetna, American Society of Hypertension, Inc., and Illinois Academy of Family Physicians.
Educational Grants
To date, the following organizations have provided educational grants in support of this Pri-Med activity:
Abbott,
Daiichi Sankyo, Inc.,
Forest Research Institute,
Merck & Co., Inc.,
Novartis Pharmaceuticals Corporation,
Novo Nordisk Inc. ,
and M|C Communications, LLC.
Session Topics
This live program consists of 9 case-based sessions. Select sessions below offer related, accredited Online CME activities. Participate in the online CME activities before the live session to prepare in advance or after the lecture to learn more about the topic. At the live program each lecture will be followed by a 15-minute networking break and complimentary lunch will be provided.
| Tuesday, December 02, 2008 |
| 7:45 AM-9:00 AM | Implementing and Monitoring Treatment in Chronic Pain: Improving Symptoms and Quality of Life Learning Objectives:- Identify advantages and disadvantages of current opioid analgesic therapies to optimize treatment for those patients most likely to benefit from opioid therapy.
- Examine how emerging technologies, including extended-release/long-acting agents, may lead to improved outcomes in patients with acute or chronic pain.
Gerald M. Sacks, MD,
Director of Pain Management,
Saint John's Health Center,
Santa Monica, CA, Director of Pain Management,
Pain Institute of Santa Monica,
Santa Monica, CA Steven Stanos, DO ,
( Read Bio)
Assistant Professor,
Northwestern University Feinberg School of Medicine,
Chicago, IL, Medical Director,
RIC Chronic Pain Center,
Chicago, IL |
| 9:15 AM-10:30 AM | Incretin-Based Therapies: Multiple Modes of Action, Multiple Clinical Benefits Learning Objectives:- List the defects in incretin secretion and action that occur in type 2 diabetes, and describe at least 3 beneficial effects of enhancing GLP-1 in this group
- Discuss the clinical efficacy and safety of incretin-based therapies for the treatment of type 2 diabetes
Scott V. Joy, MD, CDE, FACP,
Chief of Clinical Services,
Division of General Internal Medicine,
Associate Clinical Professor,
Department of Medicine,
Duke University Medical Center,
Durham, NC Harold E. Lebovitz, MD,
Professor of Medicine,
State University of New York Health Science Center at Brooklyn,
Brooklyn, NY |
| 10:30 AM-11:45 AM | "Tie Your Shoes Before You Trip!" -- Prevention of Medical Errors Learning Objectives:- Describe the systems approach to medical error prevention.
- Identify the drugs/drug classes that are at high risk for adverse drug events.
Arnold Mackles, MD, MBA, LHRM,
Licensed Healthcare Risk Manager,
Physician Speaker/Consultant,
Palm Beach Gardens, FL |
| 12:45 PM-2:00 PM | Closing the Treatment Gap: Improving the Identification and Management of Obsessive-Compulsive Disorder Learning Objectives:- Diagnose OCD appropriately and initiate pharmacologic and behavioural treatment in OCD patients.
- Evaluate treatment options for patients with drug-refractory obsessive-compulsive disorder.
James Chou, MD,
Associate Clinical Professor of Psychiatry,
Mt. Sinai Medical School ,
Glen Cove, NY, Attending Psychiatrist,
Bronx VA Medical Center,
Bronx, NY |
| 2:00 PM-3:15 PM | Strategies in Treating Cardiovascular Risk: A Focus on Hyperglycemia and Dyslipidemia Learning Objectives:-
List at least 3 ramifications of inadequate management of dyslipidemia and hyperglycemia in patient with type 2 diabetes and outline at least 2 clinician barriers to effective management of dyslipidemia and hyperglycemia in patient with type 2 diabetes.
- Outline the physiologic pathway by which bile acids effect metabolism of lipids and glucose, and understand the potential role of bile acid sequestrants in affecting both lipid parameters and blood glucose.
Peter P. Toth, MD, PhD, FAAFP, FAHA, FCCP, FACC,
Visiting Clinical Associate Professor,
Department of Family and Community Medicine,
University of Illinois College of Medicine,
Peoria, IL Lawrence Blonde, MD, FACP, FACE,
Director, Ochsner Diabetes Clinical Research Unit,
Department of Endocrinology, Diabetes, and Metabolic Diseases,
Ochsner Clinic Foundation,
New Orleans, LA |
| Wednesday, December 03, 2008 |
| 7:45 AM-9:00 AM | Fibromyalgia: Dispelling Myths, Improving Management Learning Objectives:- Dispel misinformation about fibromyalgia and rely on scientific evidence to explain its causes, recognize its manifestations, and make an accurate diagnosis.
- Analyze current pharmacologic and nonpharmacologic therapies for fibromyalgia to devise tailored, evidence-based treatment plans.
Edgar L. Ross, MD,
Director,
Pain Management Center,
Brigham & Women's Hospital,
Boston, MA Allan Gibofsky, MD ,
Professor of Medicine and Public Health,
Weill Medical College of Cornell University,
New York, NY |
| 9:15 AM-10:30 AM | Are Your Patients at Goal? A Practical Guide to Combination Therapy for Hypertension Management Learning Objectives:- List the target blood pressure levels recommended in national guidelines for patients with and without comorbid conditions (such as chronic kidney disease or diabetes mellitus) to identify the patients who are candidates for therapeutic interventions.
- Select appropriate antihypertensive strategies to achieve target BP levels, including lifestyle modification, monotherapy and combination therapies to reduce the morbidity and mortality associated with untreated/inadequately treated hypertension
Biff Palmer, MD,
Professor of Internal Medicine,
Nephrology Fellowship Program Director,
University of Texas Southwestern Medical Center,
Dallas, TX Richard Forrest Wright, MD, FACC,
Research Director,
Director,
The Heart Failure Center,
Pacific Heart Institute,
Santa Monica, CA |
| 10:45 AM-12:00 PM | Targeting HDL to Reduce Cardiovascular Disease Risk: A Call to Action Learning Objectives:- Identify barriers to achieving optimal lipid profiles, review national guidelines, and evaluate clinical studies applying intensive lipid-lowering therapy to meeting these optimal lipid goals.
- Define the importance of high-density lipoprotein cholesterol (HDL-C) in coronary risk and discuss treatment strategies to improve HDL-C within the overall lipid profile.
Michael H. Davidson, MD, FACC, FACP,
Clinical Professor of Medicine,
Director of Preventive Cardiology,
University of Chicago Pritzker School of Medicine,
Chicago, IL, Executive Medical Director,
Radiant Research ,
Chicago, IL Robert Rosenson, MD,
Director of Lipoprotein Disorders and Clinical Atherosclerosis Research,
University of Michigan School of Medicine,
Ann Arbor, MI, Senior Attending Physician,
University of Michigan Medical Center,
Ann Arbor, MI |
| 12:00 PM-1:15 PM | Diagnosis and Treatment of Alzheimer's Disease in Primary Care Learning Objectives:- Implement use of brief, practical and office-based tools to enhance recognition of AD in primary care
- Set realistic treatment expectations for patients and caregivers, and provide counseling, education, and resource information to AD patients and their caregivers
George T. Grossberg, MD,
Samuel W. Fordyce Professor,
Department of Neurology & Psychiatry,
Director, Geriatric Psychiatry,
Saint Louis University,
Saint Louis, MO David A. Smith, CMD , MD, FAAFP,
( Read Bio)
President,
Geriatric Consultants of Central Texas,
Brownwood, TX, Professor of Family Medicine,
Texas A&M University College of Medicine,
Round Rock, TX |
